131 related articles for article (PubMed ID: 6162644)
21. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
[No Abstract] [Full Text] [Related]
22. C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
Morfin RF; Charles JF; Floch HH
J Steroid Biochem; 1979 Jul; 11(1B):599-607. PubMed ID: 90752
[No Abstract] [Full Text] [Related]
23. Basis for hormonal management of advanced prostate cancer.
Geller J
Cancer; 1993 Feb; 71(3 Suppl):1039-45. PubMed ID: 7679038
[TBL] [Abstract][Full Text] [Related]
24. Androgen metabolism in rat anterior pituitary cells in culture.
Belanger A; Lundell L; Eneroth P; Gustafsson JA
Mol Cell Endocrinol; 1980 Aug; 19(2):175-81. PubMed ID: 7409304
[TBL] [Abstract][Full Text] [Related]
25. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN
BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptors in male sex tissues of rats and humans.
Attramadal A; Weddington SC; Naess O; Djoseland O; Hansson V
Prog Clin Biol Res; 1976; 6():189-203. PubMed ID: 66689
[TBL] [Abstract][Full Text] [Related]
27. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Ghanadian R; Puah CM
J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
[TBL] [Abstract][Full Text] [Related]
28. Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy.
Krieg M; Grobe I; Voight KD; Altenähr E; Klosterhalfen H
Acta Endocrinol (Copenh); 1978 Jun; 88(2):397-407. PubMed ID: 78653
[No Abstract] [Full Text] [Related]
29. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
[TBL] [Abstract][Full Text] [Related]
30. Correlative study of the morphology and C19-steroid metabolism of benign and cancerous human prostatic tissue.
Morfin RF; Leav I; Charles JF; Cavazos LF; Ofner P; Floch HH
Cancer; 1977 Apr; 39(4):1517-34. PubMed ID: 856442
[TBL] [Abstract][Full Text] [Related]
31. Interaction of prolactin and testosterone in the human prostate.
Farnsworth WE; Slaunwhite WR; Sharma M; Oseko F; Brown JR; Gonder MJ; Cartagena R
Urol Res; 1981; 9(2):79-88. PubMed ID: 6165128
[TBL] [Abstract][Full Text] [Related]
32. Tissue androgen concentrations in golden hamsters with benign prostatic tumours.
Finney RW; Harper ME; Gaskell SJ; Griffiths K
J Endocrinol; 1980 Mar; 84(3):353-61. PubMed ID: 6156223
[TBL] [Abstract][Full Text] [Related]
33. Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.
Tsugaya M; Habib FK; Chisholm GD; Ross M; Tozawa K; Hayashi Y; Kohri K; Tanaka S
Urol Res; 1996; 24(5):265-71. PubMed ID: 8931290
[TBL] [Abstract][Full Text] [Related]
34. Receptor proteins for androgens in prostatic disease.
Ghanadian R; Auf G; Chisholm GD; O'Donoghue EP
Br J Urol; 1978 Dec; 50(7):567-9. PubMed ID: 88985
[TBL] [Abstract][Full Text] [Related]
35. [In vivo interconversion of androgen].
Kiuchi T; Miyazaki T; Kato T; Araki Y
Nihon Rinsho; 1974 Nov; 32(11):3302-8. PubMed ID: 4375211
[No Abstract] [Full Text] [Related]
36. In vitro uptake of 3H testosterone and its conversion to dihydrotestosterone by prostatic carcinoma and other tissues.
Prout GR; Kliman B; Daly JJ; Maclaughlin RA; Griffin PP
J Urol; 1976 Nov; 116(5):603-10. PubMed ID: 62062
[TBL] [Abstract][Full Text] [Related]
37. Testosterone metabolism of fibroblasts grown from prostatic carcinoma, benign prostatic hyperplasia and skin fibroblasts.
Schweikert HU; Hein HJ; Romijn JC; Schröder FH
J Urol; 1982 Feb; 127(2):361-7. PubMed ID: 6174738
[TBL] [Abstract][Full Text] [Related]
38. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
39. Androgen assimilation by normal and hyperplastic dog prostate glands.
Mawhinney MG; Schwartz FL; Thomas JA; Lloyd JW
Invest Urol; 1974 Jul; 12(1):17-22. PubMed ID: 4135034
[No Abstract] [Full Text] [Related]
40. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
Gloyna RE; Siiteri PK; Wilson JD
J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
